© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 50MCG/0.25MLBST S | Medium Descr | IMM ADMN SARSCOV2 50 MCG/0.25 ML BOOSTER DOSE | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, booster dose | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | CR | Catastrophe/disaster related | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GW | Service not related to the hospice patient's terminal condition | SA | Nurse practitioner rendering service in collaboration with a physician |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2024-01-01 | Note | First appearance of 2022 AMA guideline changes. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-04-18 | Note | Changes made to dosing information |
| 2023-04-18 | Note | These codes (associated with 0064A) are no longer authorized for use in the United States: 91301, 91306 91309, 91311. |
| 2023-04-18 | Note | No longer authorized for use in the United States. |
| 2023-01-01 | Added | First appearance in codebook. |
| 2023-01-01 | Note | First appearance of guideline change(s) in codebook. |
| 2022-12-08 | Note | AMA Guideline changed. 91316 received FDA approval. |
| 2022-11-16 | Note | AMA guideline changed. 91316 will be effective upon receiving EUA or FDA approval. |
| 2022-10-12 | Note | AMA Guideline changed. 91313 (12 yrs through 17 yrs) and 91314 received FDA approval. |
| 2022-08-31 | Note | AMA Guideline changed. 91313 (18 yrs & older) received FDA approval effective immediately. |
| 2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age to 18+. |
| 2022-08-31 | Note | AMA guideline changed to include 91313, 91314 effective upon receiving emergency Use Authorization or approval from the FDA. |
| 2022-06-17 | Note | AMA Guideline changed. 91311 received approval. |
| 2022-05-19 | Note | AMA guideline changed to include 91311 effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-03-29 | Note | AMA Guideline changed. 91309 received approval. |
| 2022-03-07 | Note | New AMA guideline added. Includes 91301 & 91309 published to website prior to the addition of 0064A. 91301 also received FDA approval prior. |
| 2021-10-20 | Note | AMA Guideline changed. 91306 received approval. |
| 2021-10-20 | Added | Code added. |
| 2021-10-20 | Note | FDA approval granted. |
| 2021-09-03 | Note | AMA guideline changed to include 91306 effective upon receiving Emergency Use Authorization or approval from the FDA |
| 2021-09-03 | Added | Published on AMA website. Effective upon receiving Emergency Use Authorization or approval from the Food and Drug Administration. |